Corvus Pharmaceuticals Inc (CRVS)
2.03
-0.03
(-1.46%)
USD |
NASDAQ |
May 28, 16:00
2.02
-0.01
(-0.49%)
After-Hours: 20:00
Corvus Pharmaceuticals Price: 2.03 for May 28, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 28, 2024 | 2.09 | 2.10 | 1.93 | 2.03 | 451980.0 |
May 24, 2024 | 2.09 | 2.11 | 2.00 | 2.06 | 169008.0 |
May 23, 2024 | 2.09 | 2.155 | 1.99 | 2.07 | 265963.0 |
May 22, 2024 | 2.18 | 2.24 | 2.10 | 2.14 | 132364.0 |
May 21, 2024 | 2.26 | 2.29 | 2.17 | 2.18 | 122571.0 |
May 20, 2024 | 2.30 | 2.35 | 2.17 | 2.28 | 192818.0 |
May 17, 2024 | 2.16 | 2.34 | 2.11 | 2.29 | 252758.0 |
May 16, 2024 | 2.25 | 2.27 | 2.15 | 2.19 | 173800.0 |
May 15, 2024 | 2.25 | 2.35 | 2.15 | 2.22 | 239573.0 |
May 14, 2024 | 2.12 | 2.320 | 2.063 | 2.26 | 537260.0 |
May 13, 2024 | 2.10 | 2.16 | 2.01 | 2.11 | 319852.0 |
May 10, 2024 | 2.05 | 2.17 | 1.91 | 2.08 | 307162.0 |
May 09, 2024 | 2.10 | 2.19 | 1.97 | 2.03 | 677052.0 |
May 08, 2024 | 1.87 | 2.00 | 1.83 | 1.96 | 658504.0 |
May 07, 2024 | 1.81 | 1.94 | 1.43 | 1.68 | 1.018M |
May 06, 2024 | 2.09 | 2.09 | 1.83 | 1.91 | 1.050M |
May 03, 2024 | 1.81 | 2.08 | 1.75 | 1.92 | 381059.0 |
May 02, 2024 | 1.76 | 1.78 | 1.68 | 1.73 | 453252.0 |
May 01, 2024 | 1.53 | 1.647 | 1.51 | 1.61 | 80682.00 |
Apr 30, 2024 | 1.60 | 1.60 | 1.53 | 1.55 | 56501.00 |
Apr 29, 2024 | 1.48 | 1.61 | 1.44 | 1.58 | 131930.0 |
Apr 26, 2024 | 1.56 | 1.619 | 1.44 | 1.45 | 124494.0 |
Apr 25, 2024 | 1.47 | 1.52 | 1.410 | 1.48 | 66282.00 |
Apr 24, 2024 | 1.60 | 1.60 | 1.49 | 1.51 | 90571.00 |
Apr 23, 2024 | 1.43 | 1.57 | 1.43 | 1.53 | 137350.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.6481
Minimum
Mar 28 2023
8.53
Maximum
Sep 21 2021
2.596
Average
2.40
Median
Mar 13 2020
Price Benchmarks
Cyclacel Pharmaceuticals Inc | 2.01 |
Enanta Pharmaceuticals Inc | 11.93 |
Oragenics Inc | 2.12 |
Nanoviricides Inc | 2.20 |
MAIA Biotechnology Inc | 4.11 |
Price Related Metrics
Price to Book Value | 3.806 |
Earnings Yield | -25.12% |
Market Cap | 126.98M |